Showing results (181-190 of 688) with videos related to

Sort By:
Pageof 69
Arthritis Research & Therapy|May 16, 2019
ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentationDebbie M Boeters, Leonie E Burgers, Eric H Sasso, et al.
Lupus|June 3, 2016
Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosusC Magro-Checa, R A Schaarenburg, H J L Beaart, et al.
Annals of the Rheumatic Diseases|April 8, 2011
Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritisErlangga Yusuf, Andreea Ioan-Facsinay, Jessica Bijsterbosch, et al.
Annals of the Rheumatic Diseases|April 26, 2015
The diagnostic accuracy of the squeeze test to identify arthritis: a cross-sectional cohort studyW B van den Bosch, L Mangnus, M Reijnierse, et al.
Trials|January 8, 2020
Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocolMeriem Manaï, Henriët van Middendorp, Dieuwke S Veldhuijzen, et al.
Arthritis Research & Therapy|November 5, 2016
The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ moleculesArieke S B Kampstra, Jurgen van Heemst, Antonis K Moustakas, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Rheumatology International|February 6, 2019
Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Osteoarthritis and Cartilage|May 19, 2010
Doyle Index is a valuable additional pain measure in osteoarthritisJ Bijsterbosch, M J E Wassenaar, S le Cessie, et al.
Arthritis Research & Therapy|October 29, 2011
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?Diederik P C De Rooy, Annemiek Willemze, Bart Mertens, et al.
Pageof 69